Danel (Adir Yeoshua) Ltd (TLV: DANE)
Israel
· Delayed Price · Currency is ILS · Price in ILA
43,500
+420 (0.97%)
Jan 19, 2025, 3:49 PM IDT
Danel (Adir Yeoshua) Revenue
Danel (Adir Yeoshua) had revenue of 705.16M ILS in the quarter ending September 30, 2024, with 10.75% growth. This brings the company's revenue in the last twelve months to 2.71B, up 9.99% year-over-year. In the year 2023, Danel (Adir Yeoshua) had annual revenue of 2.51B with 6.34% growth.
Revenue (ttm)
2.71B
Revenue Growth
+9.99%
P/S Ratio
0.91
Revenue / Employee
683.86K
Employees
3,961
Market Cap
2.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.51B | 149.89M | 6.34% |
Dec 31, 2022 | 2.36B | 75.20M | 3.29% |
Dec 31, 2021 | 2.29B | 303.89M | 15.31% |
Dec 31, 2020 | 1.98B | 306.79M | 18.28% |
Dec 31, 2019 | 1.68B | 185.54M | 12.43% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 62.35B |
Kamada | 588.75M |
Bait Bakfar | 102.08M |
Novolog (Pharm-Up 1966) | 1.73B |
Ilex Medical | 982.96M |
BrainsWay | 143.60M |
SofWave Medical | 210.53M |
Golden House | 47.96M |